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SUMMARY 
[ 14C] Aflatoxin B 1 (AFB1 ) was isolated from cultures of Aspergillus 
parasiticus grown on [1-14C] sodium acetate. Covalent binding of AFB1 
to liver DNA of rat and mouse was determined 6-8 h afteroral adminis-
tration. The effectiveness of covalent binding, expressedas DNA binding per 
dose in the units of a 'Covalent Binding Index' (CBI), (llmol aflatoxin/mol 
DNA nucleotides)/(mmol aflatoxin/kg animal), was found to be 10 400 for 
rats and 240 for mice. These CBI partly explain the different susceptibility 
of the two species for the incidence of hepatic tumors. 
· The corresponding values for pig liver DN A, 24 and 48 h after oral admin-
istration, were found to be as high as 19 100 and 13 300. DNA-binding has 
not so far been reported for this species although it could represent an 
appropriate animal model for studies where a human-like gastrointestinal 
tract physiology is desirable. 
Aflatoxin M 1 ( AFM 1) is a metabolite found in the milk of cows that have 
been fed AFB 1-contaminated diet. [ 14C] AFr.1 1 was also found to be pro-
duced by cultures of A. parasiticus giving a yield of about 0.3% of the total 
aflatoxins. A test for covalent binding to rat liver DN A revealed a CBI of 
2100 shoWing that AFM 1 must also be regarded as a strong hepatocar-
cinogen .. It is concluded that AFB1 contaminations should be avoided in 
dairy feed. 
INTRODUCTION 
Aflatoxins are highly toxic mould metabolites and frequent contaminan~ 
of groundnut cake used in animal nutrition. The main representative of this 
Abbreviations: .AF, afiatoxin; AFB1, afiatoxin B1 ; AFM1 , afiatoxin M1 ; CBI, Covalent 
Binding Index 
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class of compounds, AFB1 (1), is known to be the mostpotent hepatocar-
cinogen for animals [ 1,2] . Epidemiological studies suggest that the prevalence 
of human liver cancer in certain tropical areas of the world is correlated 
with the intake of aflatoxins [3]. 
0 0 
II 
The mode of carcinogenic action of AFB 1 probably involves a covalent 
interaction of a reactive metabolite, most likely the 8,9-epoxide* [ 4, 5, and 
references therein], with biologi.cal macromolecules in the ta.rget organ [6, 
and references therein]. Since DNA seems to be the most critical site of 
attack for the initiation of a tumor [for a review, see Ref. 7], the extent of 
such a covalent interaction of chemieals with DN A appears to be a useful 
quantitative indicator in the process of chemical carcinogenesis. 
The susceptibility of man to the carcinogenic activity of AFB 1 is not 
known and must be extrapolated from animal data. It would be advant-
ageaus to base upon an animal model with pharmacokinetics similar tothat 
of man. An animal species which resembles man at least with respect to the 
physiology of the gastrointestinal tract and the rate of basal metabolism is the 
pig. lts susceptibility to the carcinogenic action of aflatoxins is estimated in 
this report on the basis of covalent binding of AFB1 tO pig liver DNA. It will 
also be shown that the known düference in the susceptibility between the 
rat and the mouse is iildeed reflected by düferent degrees of DNA binding. 
AFM1 (II) is a metabolite of AFB1 formed in all mammals studied so far. 
About 1% of orally ingested AFB1 is secreted as AFM1 in the milk of 
cows [8]. Low Ievels of AFM1 are therefore regularly detected in milk 
when groundnut cake has been fed, and it would be important to know 
more about its carcinogenicity. AF}tl 1 has been studied in the rainbow 
trout and was found to be strongly hepatocarcinogenic [9,10]. Due to Iack 
of material, only preliminary studies have been performed with mammals 
[11,12] and no definite conclusions on its potency could be drawn. 
We were able to purify [ 14C] AFM 1 from a culture of A. parasiticus and to 
measure the covalent binding of AFM 1 to rat Ii ver DN A after oral adminis-
tration. The results indicate a strong carcinogenicity of AF~:f 1 in mammals. 
*Previously called the 2,3-oxide but renumbered according to IUPAC recommendations. 
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MATERIALS AND METHODS 
Materials 
Reagents without specified distributor were of the highest purity available 
from Merck, Darmstadt, F.R.G. 
[14C] AFB1• It. was prepared biosynthetically from (1)4C] sodium acetate 
with A. parasiticus ATCC 15517 as outlined by Hsieh and :M:ateles [13]. 
Purity and identity of the compound obtained was checked with thin-layer 
chromatography by comparison with authentic AFB., supplied by Senn 
Chemicals, Dielsdorf, Switzerland. The incorporation efficiency of the 
various batches varied between 1% and 2%. The specific activity of AFB 1 
used for the different binding experiments was determined to be 20.3 or 
15.5 mCi/mmol, and a radiochemical purity of >95% was achieved. 
P 4C] AFM 1• It was found in various biosynthetic preparations that 
A. parasiticus ATCC 15517 produced small amounts of AF~~. (0.3% of the 
total AF production). ( 14C] AFM 1 was obtained as a by-product of biosYn-
thetically prepared [ 14C] AFB1 and purified by repeated chromatography on 
silicagel G (solvent systems: chloroform/acetone (88: 12) and chloroform/ 
isoamyl alcohol/acetone (80 : 10·: 10). UV- and mass spectra as weil as 
chromatographic properlies of the purified compound were completely 
identical with the corresponding data of authentic AFM 1 (supplied by Senn 
Chemicals, Dielsdorf, Switzerland). The radiochemical purity was >90% and 
no other AF was detectable with thin-layer chromatography at a Iimit of 
detection of 0.2% AFB1• The specific activity of the three samples used was 
31.5, 15.5 and 3. 7 mCi/mmol. 
Animals and treatments 
Isolation of DNA. Male rats (ZUR:SIV-Z), male mice (ZUR:ICR-Z) and 
female pigs (Hampshire x Deutsches Edelschwein) were obtained from the 
Kantonales Tierspital, Zürich, Switzerland. The weights are given in Tables I 
and II. The aflatoxins were administered by gavage in 10% aqueous ethanoL 
The isolation and purification of DNA was perfonned according to 
Markov and Ivanov [14] with the modifications as described before [15]. 
Control experiments for binding of [1 4C} AF-radioactivity to DNA with-
out enzymatic activation. 63 000 dpm AFB1 was shaken for 1 h at 37°C 
with the total homogenate of 7.5 g rat liver in 50 mllysing medium (0.24 :M 
sodium phosphate (pH 6.8) 8 M urea, 1% sodium dodecylsulfate, 0.01 :M 
EDTA) [14]. The gross radioactivity of 3.1 mg DNA isolated after this 
incubation was 40.3 cpm in an integral 14C channel and did not significantly 
differ from the 40.4 cpm of 2.4 mg DNA from an inactive liver. A similar 
incubation of 33 700 dpm AFM 1 with 10.2 g liver in 50 mllysing medium 
for 4.5 h at room temperature yielded a sample of 2.6 mg DNA with 
21.3 cpm (narrow channel) as compared with 22.1 cpm from 2.4 mg DNA of 
an inactive liver. 
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RESULTS 
The binding experiments with AFB1 and AFI':f 1 are compiled in Tables I 
and II, respectively. The effectiveness of covalent binding is expressed in the 
CBI units used throughout our DN A binding experiments. 
CBI = JZMOI AF bound/mol DNA nucleotide 
mmol AF administered/kg body wt. 
This equation shows how many molecules of the test compound are 
bound per 106 nucleotides after the theoretical administration of 1 mmol/ 
kg animal. 
Most Iiterature data on DN A binding by aflatoxins are based upon intra-
peritoneal injections [6, and references therein]. Since the oral route should 
be preferred for a toxicological evaluation of a food contaminant, we deter-
mined in one experiment whether the route of administration has any effect 
on the CBI. The first three lines of Table I reveal that the CBI obtained 
after i.p. injection was similar to the mean CBI obtained afteroral adminis-
tration. The three values were therefore combined and a mean of 10 400 was 
obtained for AFB1 and rat liver DNA. 
The CBI for mouse liver· DN A was 240 whereas the pig revealed a high er 
effectiveness of binding than the rat, even at 48 h after the administration. 
The radiobiosynthesis of AF~·1 1 has never been described before, nor a 
DNA-binding experimentever reported. The amount of [ 14C] AF~.1 1 obtained 
was small, but each of the three batches was sufficient to determine the 
covalent bindingtoliver DNA in one rat (Table 11). The individual difference 
between the three animals was marked, but the order of magnitude was 
clearly around 2000. This relatively high CBI shows that the hydroxylation 
of AFB1 to AFM 1 reduced its effectiveness of covalent DN A binding by a 
factor of five only. 
The presence of radioactivity on the DN A of a treated animal does not, 
a priori, prove covalent DNA binding. The radioactive molecule might have 
undergone non-covalent interaction with DNA, or a radioactive fragment 
might have been incorporated biosynthetically. However, the control experi-
ments showed, that intercalated aflatoxins are completely removed from 
the DN A in the purification process. Secondly, it was shown that the 14C-
label from [ l-14C1 acetate is incorporated into metabolically stable positions 
of AF (16]. Only 0.5% of the radioactivity is recovered as [14C]carbon 
dioxide if a dose of [ 14C 1 AFB 1 iS administered to a rat [ 171 . In addition, 
the biosynthetic incorporation of one-carbon fragments into DNA is much 
less efficient than the binding of AFB1• The incorporation of radioactivity 
of (14C] methanol into mouse liver DNA, 12 h af'OOr oral administration, was 
only about 25, when expressed in the same CBI units as used for the afla-
toxins (unpublished data). It is therefore evident that the radioactivity 
measured on the DNA obtained from the aflatoxin experiments represents 
true covalent adduct formation. 
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TADLE II 
COVALENT BINDING OF AFM 1 TO RAT LJVER DNA. 6 H AFTER ORAL ADMINISTRATION 
Anima! Dose Radioaet. %total Spee. act. Effeetiveness of covalent binding 
wt. (g) admin. admin. dosein ofDNA 
(Jlg/kg) (dpm/kg) Uver at (dpm/mg) lo'mol AF/mol 
time of dpm/mg DNA nucleotide 
sacrifice CBI= 
dpm/kg body wt. mmol AF/kg 
body wt. 
265 3.6 7.7 • 105 ND 1.9 2.4 • 10-6 
231 8.2 8.6. 105 ND 7.0 8.2 • 10-6 2100 i_ 1200 
282 20.9 5.2. 105 5.0 4.9 9.5 • 10-6 
DISCUSSION 
AFB1• The finding that the route of administration does not alter the CBI 
for Iiver DNA is a clear indication that the liver takes over most of the meta-
bolism of AFB1• This is in agreement with the fact that the carcinogenic 
activity of AFB1 is directed almost exclusively towards this organ. It is 
interesting to note that, on a weight basis, there is even a strong accumu-
lation of AFB1 bound to liver DNA. For instance, line 1 of Table I 
shows that after a dose of 2.6 · 106 dpm/kg body weight a specific activity 
of 89 • 106 dpm/kg DNA resulted. A similar accumulation can be observed 
with the methylation of liver DNA by dimethylnitrosamine [7] and is an 
indication of strong carcinogenicity of the compound under investigation. 
The binding of AFB 1 to liver DN A was lower by a factor of 40 in mice 
than in rats. This reflects the different susceptibility of the two species to 
the hepatocarcinogenic activity of AFB 1 which is at least 100 times lower 
in mice than in rats [18]. While this manuscript was in revision, similar 
species differences for the binding of AFB1 to hepatic macromolecules were 
reported [19]. These authors found a düference of a factor of 700 between 
rat and mouse liver DNA, 1.5 h after i.p. injection. The discrepancy to our 
results can in part be due to the use of other strains, in part to the choice 
of a different time between administration and sacrifice. 1.5 h might have 
been too short for a maximum binding to occur in the mouse becau8e it 
was reported that the transport of AFB1 into hepatic cells is slower in the 
mouse than in the rat [20]. This assumption is substantiated by the fact 
that the fraction of the radioactivity in whole mouse liver amounted to 
0.7% in their experiment as opposed to more than 2% in ours (Table 1), at 
8 h afteroral administration. The corresponding values for rat liver, 11.1% 
and 9%, respectively, correspond much better. 
Several earlier studies have dealt with the time dependence for the DNA-
aflatoxin adducts. The amount of DNA-bound carcinogen rises steeply 
after an i.p. administration, reaches a maximum value around 2 h [6,21] and 
decreases thereafter with an approximate half-life of 10 h [21] to 15 h [22]. 
Other studies report a time of 6 h for maximum binding [ 23] or a plateau 
Ievel between 2 h and 6 h [22]. We chose a time lag of 6-8 hin order to 
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account for a slower distribution after oral administrationo It is possible 
that these time points yield CBI values that are a few percent off the maxi-
mumo This will ,not, however' markedly affect a discussion of the relative 
susceptibility of rat and mouseo 
Our DNA binding experiments with the pig are, to our knowledge, the 
first studies with this species which is an appropriate animal model for the 
study of processes for which a human-like physiology of the gastrointestinal 
system might be desirable. The CBI of more than ten thousand, at 24 h and 
48 h after the administration, indicate that the pig might be highly suscep-
tible to the carcinogenic activity of AFB1o The difference to the rat becomes 
even more evident if it is considered that the CBI for the rat has decreased 
to 1500 and 1100 at 24 h and 48 h, respectively [6] o The high CBI obtained 
with the pig could therefore be due to low DNA repair capability but it 
would be premature for a firm statement on the basis of only two detennina-
tions. First of all, it is obvious from data with the rats that appreciable indi-
vidual variability is observed for CBI obtained under identical conditions, 
and secondly, it is probable that the maximum DNA binding is reached later 
in the bigger animal. 
AFM 1• The CBI for rat liver DNA has been shown to correlate semi-
quantitatively with the carcinogenic potency of a compound [7] 0 It was 
shown that a CBI of 103-104 stands for strong hepatocarcinogens, a CBI 
of 102 for moderate, and of about ten for weak hepatocarcinogens. An 
extensive discussion [ 7] of the predictive value of a CBI revealed that a 
comparison of structurally related chemieals like AFB1 and AF!\1t can very 
well be based quantitatively upon measurement of DNA bindingo 
The difference between AFB1 and AFM 1 in hepatoma incidence in the 
trout was found to be of a factor of 4 [9], the difference in the Salmonella/ 
microsome mutagenicity testwas about 30: 1 in one report [24] and about 
3 : 1 in another [25]. The rate data on carcinogenicity in the rat cannot be 
used for a quantitative comparison of the two compounds [11,12]. Our 
binding values with rats suggest that AF~1 1 will be somewhat less carcino-
genic than AFBtt the ratio beingabout 1 : 5. AFM1 must therefore still be 
classified with the strong hepatocarcinogens and, due to the carry-over of 
aflatoxins from feed to the milk, extreme caution should be exerted in the 
feeding of milk cows with AFB 1 contaminated feed. 
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